CHIRON CAPITAL MANAGEMENT, LLC - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 252 filers reported holding TG THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.81 and the average weighting 0.3%.

Quarter-by-quarter ownership
CHIRON CAPITAL MANAGEMENT, LLC ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$235,980
+29.7%
9,500
-21.5%
0.19%
+47.2%
Q1 2023$181,984
+44.9%
12,100
+14.0%
0.13%
+46.0%
Q4 2022$125,599
+173.0%
10,617
-0.9%
0.09%
+200.0%
Q2 2022$46,000
-64.6%
10,717
-21.7%
0.03%
-64.6%
Q1 2022$130,000
-42.0%
13,692
+16.3%
0.08%
-49.4%
Q4 2021$224,000
+89.8%
11,772
+166.0%
0.16%
+70.5%
Q3 2020$118,0004,4250.10%
Other shareholders
TG THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Jetstream Capital LLC 200,000$7,758,0005.97%
Lion Point Capital, LP 609,128$23,628,0004.08%
RA Capital Management 3,342,743$129,665,0002.08%
Ghost Tree Capital, LLC 180,000$6,982,0001.92%
Nicholas Investment Partners, LP 660,964$25,639,0001.61%
ARDSLEY ADVISORY PARTNERS LP 350,000$13,577,0001.60%
SECTORAL ASSET MANAGEMENT INC 414,949$16,096,0001.30%
Spotlight Asset Group, Inc. 75,000$2,909,0001.12%
ACT CAPITAL MANAGEMENT, LLC 55,000$2,134,0001.10%
Pier Capital, LLC 280,486$10,880,0001.09%
View complete list of TG THERAPEUTICS INC shareholders